179 related articles for article (PubMed ID: 32910558)
1. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
Wang Z; Zhao Y; Xu H; Liang F; Zou Q; Wang C; Jiang J; Lin F
J Cell Mol Med; 2020 Oct; 24(19):11445-11456. PubMed ID: 32910558
[TBL] [Abstract][Full Text] [Related]
2. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
3. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
[TBL] [Abstract][Full Text] [Related]
5. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
Tu W; Gong J; Zhou Z; Tian D; Wang Z
Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
[TBL] [Abstract][Full Text] [Related]
6. CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis.
Yang G; Zhang C
Environ Sci Pollut Res Int; 2022 May; 29(25):38385-38394. PubMed ID: 35076836
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
8. LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.
Zhao L; Wang G; Qi H; Yu L; Yin H; Sun R; Wang H; Zhu X; Yang A
Cell Mol Biol Lett; 2024 May; 29(1):77. PubMed ID: 38769475
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
10. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
11. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
13. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
[TBL] [Abstract][Full Text] [Related]
16. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway.
Li J; Li Y; Wang B; Ma Y; Chen P
J Biomed Sci; 2017 Dec; 24(1):95. PubMed ID: 29233161
[TBL] [Abstract][Full Text] [Related]
17. IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer.
Yang L; Dong Y; Li Y; Wang D; Liu S; Wang D; Gao Q; Ji S; Chen X; Lei Q; Jiang W; Wang L; Zhang B; Yu JJ; Zhang Y
Int J Cancer; 2019 Aug; 145(4):1099-1110. PubMed ID: 30671927
[TBL] [Abstract][Full Text] [Related]
18. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of EI2BL promoted human non-small cell lung cancer progression by inducing cell EMT phenotype.
Li HR; Qiu BQ; Gao J; Jin C; Jiang JH; Ding JY
J Clin Pathol; 2020 Mar; 73(3):139-146. PubMed ID: 31586937
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
